If you don't have cancer.
[Don't actually make the bracha but you get my point....]
Statistics at a Glance: The Burden of Cancer in the United States
[A little bit outdated but you get the point]
In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease.
The number of new cases of cancer (cancer incidence) is 454.8 per 100,000 men and women per year (based on 2008-2012 cases).
The number of new cases of cancer (cancer incidence) is 454.8 per 100,000 men and women per year (based on 2008-2012 cases).
The number of cancer deaths (cancer mortality) is 171.2 per 100,000 men and women per year (based on 2008-2012 deaths).
Cancer mortality is higher among men than women (207.9 per 100,000 men and 145.4 per 100,000 women). It is highest in African American men (261.5 per 100,000) and lowest in Asian/Pacific Islander women (91.2 per 100,000). (Based on 2008-2012 deaths.)
The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024.
Approximately 39.6% of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2010-2012 data).
In 2014, an estimated 15,780 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,960 died of the disease.
----------
----------
General Blood Cancers
New Cases
Approximately every 3 minutes one person in the United States (US) is diagnosed with a blood cancer.
An estimated combined total of 172,910 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2017.
New cases of leukemia, lymphoma and myeloma are expected to account for 10.2 percent of the estimated 1,688,780 new cancer cases diagnosed in the US in 2017.
Prevalence
Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,290,773 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.
Survival
Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.
Deaths
Approximately every 9 minutes, someone in the US dies from a blood cancer. This statistic represents approximately 160 people each day or more than six people every hour.
Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,300 people in the US in 2017.
These diseases are expected to account for 9.7 percent of the deaths from cancer in 2017, based on the estimated total of 600,920 cancer deaths.
Leukemia
New Cases
In 2017, 62,130 people are expected to be diagnosed with leukemia.
Prevalence
There are an estimated 363,794 people living with, or in remission from, leukemia in the US.
Survival
The overall five-year relative survival rate for leukemia has more than quadrupled since 1960. From 1960 to 1963, the five-year relative survival rate among whites (only data available) with leukemia was 14 percent. From 1975 to 1977, the five-year relative survival rate for the total population with leukemia was 34.2 percent, and from 2006 to 2012, the overall relative survival rate was 62.7 percent.
From 2006-2012, the five-year relative survival rates overall were
CML - 65.9 percent
CLL - 85.1 percent
AML - 26.8 percent overall and 66.8 percent for children and adolescents younger than 15 years
ALL - 70.7 percent overall, 92.3 percent for children and adolescents younger than 15 years, and 94.1 percent for children younger than 5 years.
Deaths
In 2017, 24,500 people are expected to die from leukemia (14,300 males and 10,200 females).
In 2009-2013, leukemia was the fifth most common cause of cancer deaths in men and the sixth most common in women.
Hodgkin (HL) and Non-Hodgkin (NHL) Lymphoma
New Cases
In 2017, there are expected to be 80,500 new cases of lymphoma diagnosed in the US (8,260 cases of HL, 72,240 cases of NHL).
Prevalence
In 2017, there are an estimated 816,634 people living with, or in remission from, lymphoma in the US.
There are 186,607 people living with Hodgkin lymphoma
There are 630,027 people living with non-Hodgkin lymphoma
Survival
The 5-year relative survival rate for people with HL has more than doubled, from 40 percent in whites from 1960 to 1963 (only data available) to 88.5 percent for all races from 2006 to 2012. The five-year relative survival rate is 94.3 percent for people with HL who were less than 45 years old at diagnosis.
HL is now considered to be one of the most curable forms of cancer.
The 5-year relative survival rate for people with NHL has risen from 31 percent in whites from 1960 to 1963 (only data available) to 72.6 percent for all races from 2006 to 2012.
Deaths
In 2017, an estimated 21,210 members of the US population are expected to die from lymphoma (20,140 NHL and 1,070 HL).
Myeloma
New Cases
An estimated 30,280 new cases of myeloma (17,490 males and 12,790 females) are expected to be diagnosed in the US in 2017.
Prevalence
An estimated 110,345 people in the US are living with, or in remission from, myeloma.
Survival
Five-year relative survival has increased from 12 percent in 1960-1963 among whites (only data available) to 50.2 percent from 2006 to 2012 (for all races and ethnicities).
The 3-year survival rate as of January 1, 2013, is 65.0 percent (for all races and ethnicities).
Deaths
Approximately 12,590 deaths from myeloma are anticipated in 2017.
Myelodysplastic Syndromes (MDS)
New Cases
For the 5-year period from 2009 to 2013, there were approximately 76,755 new cases of MDS throughout the US, averaging an estimated 15,351 cases per year.
Approximately 43,518 cases were diagnosed in males (averaging 8,704 per year) and approximately 33,237 cases were diagnosed in females (averaging 6,647 per year).
